Quick Takeaways
- Rosalind Advisors, Inc. filed SCHEDULE 13G/A for KIORA PHARMACEUTICALS INC Common Shares (KPRX).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2024.
Rosalind Advisors, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for KIORA PHARMACEUTICALS INC Common Shares (KPRX)
- Filing Manager
- Rosalind Advisors, Inc.
- Reporting Manager
- Rosalind Advisors, Inc.
- Symbol
- KPRX
- Shares outstanding
- 7,224,556 shares
- Disclosed Ownership
- 715,231 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2025, 16:03:44 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Rosalind Advisors, Inc. disclosed 9.9% ownership in KIORA PHARMACEUTICALS INC Common Shares (KPRX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 16:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.9% | 715,231 | 0 | 715,231 | Steven Salamon | President | |
| SALAMON STEVEN A J | 9.9% | 715,231 | 0 | 715,231 | Steven Salamon | Steven Salamon | |
| Aharon Gil | 9.9% | 715,231 | 0 | 715,231 | Gil Aharon | Gil Aharon | |
| Rosalind Master Fund L.P. | 9.9% | 715,231 | 0 | 715,231 | Mike McDonald | Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund) |